Disease progression and characteristics of HIV-infected women with and without a history of criminal justice involvement

AIDS and Behavior

Volumn 17, Issue 8, 2013, Pages 2644-2653

  Youmans, Eren ^a   Burch, James ^a,b   Moran, Robert ^a   Smith, Lillian ^a   Duffus, Wayne A ^c,d  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b WJB Dorn Veteran's Affairs Medical Center   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d SOUTH CAROLINA DEPARTMENT OF HEALTH AND ENVIRONMENTAL CONTROL   (United States)

Author keywords

Correctional facilities; Epidemiology; HIV; Southeastern United States; Women

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; CRIMINAL LAW; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; OFFENDER; PRISON; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; CRIMINAL LAW; CRIMINALS; DISEASE PROGRESSION; FEMALE; HIV SEROPOSITIVITY; HUMANS; MIDDLE AGED; PRISONS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84885434378     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-011-0057-1     Document Type: Article

References (32)

1. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New Engl J Med. 1998;338(13):853-60.
2. Jacobson MA, French M. Alternated natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy. AIDS. 1998;12(Suppl A):S157-63.
3. Murphy EL, Collier AC, Kalish LA, Assman SF, Para MF, Flanigan TP, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced disease. Ann Intern Med. 2001;135:17-26.
4. Langford SE, Ananworanich J, Cooper DA. Predictors of disease progression in HIV infection: a review. AIDS Res Ther. 2007;4(11):1-14.
5. Nicastri E, Angeletti C, Palmisano L, Sarmati L, Chiesi A, Geraci A, et al. Gender differences in clinical progression of HIV-1 infected individuals during long-term highly active antiretroviral therapy. AIDS. 2005;19:577-83.
6. Melnick SL, Sherer R, Louis TA, Hillman D, Rodriguez EM, Lackman C, et al. Survival and disease progression according to gender of patients with HIV infection. JAMA. 1994;272(22):1915-21.
7. Del Amo J, Petruckevitch A, Phillips A, Johnson AM, Stephenson J, Desmond N, et al. Disease progression and survival in HIV-1-infected Africans in London. AIDS. 1998;12(10):1203-9.
8. Poundstone KE, Chaisson RE, Moore RD. Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS. 2001;15:1115-23.
9. Clark RA, Blakley SA, Rice J, Brandon W. Predictors of HIV disease progression in women. J Acquir Immune Defic Syndr. 1995;9(1):43-50.
10. Laine C, Markson LE, McKee LJ, Hauck WW, Fanning TR, Turner BJ. The relationship of clinic experience with advanced HIV and survival of women with AIDS. Am J Public Health. 1997;12(4):417-24.
11. Griffin MM, Ryan JG, Briscoe VS, Shadle KM. Effects of Incarceration on HIV-Infected Individuals. J Natl Med Assoc. 2010;88(10):639-44.
12. Khan MR, Wohl DA, Weir SS, Adimora A, Moseley C, Norcott K, et al. Incarceration and risky sexual partnerships in a Southern US City. J Urban Health. 2007;28(1):100-13.
13. Khan MR, Doherty IA, Schoenbach VJ, Taylor EM, Epperson MW, Adimora AA. Incarceration and high-risk sex partnerships among men in the United States. J Urban Health. 2011;86(4):584-601.
14. Spaulding A, Stephenson W, Macalino G, Ruby W, Clarke JG, Flanigan TP. Human immunodeficiency virus in correctional facilities: a review. CID. 2002;35(3):305-12.
15. Meyer JP, Chen NE, Springer SA. HIV treatment in the criminal justice system: critical knowledge and intervention gaps. AIDS Res Treat. 2011;2011:680617. doi: 10.1155/2011/680617.
16. Mahajan AP, Sayles JN, Patel VA, Remien RR, Ortiz D, Szekeres G, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS. 2008;22(Suppl 2):S67-79.
17. Baillargeon J, Giordano TP, Harzke AJ, Spaulding AC, Wu ZH, Grady JJ, et al. Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care STDs. 2010;24(6):389-94.
18. Palepu A, Tyndall MW, Chan K, Wood E, Montaner JSG, Hogg RS. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antivir Ther. 2004;9:713-9.
19. US Department of Health and Human Services HRaSAHAB. Outreach: engaging people in HIV care. Health Resources and Services Administration, HIV/AIDS Bureau 2010 [cited 2010 Nov 5]. Available from: www.hab.hrsa.gov/tools/ HIVoutreach/HIVoutreach2.htm#2a.
20. Panel of Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services; 2008.
21. Ghali WA, Quan H, Brant R, Melle G, Norris CM, Faris PD, et al. Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. JAMA. 2001;286(12):1494-7.
22. The White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States; 2011.
23. The Constitution of thre United States of America, Amendment 8; 2010.
24. Stephenson BL, Wohl DA, Golin CD, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral load of HIV-infected individuals. Public Health Rep. 2005;120:84-8.
25. Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarcertation and the lack of sustained benefit after release to the community. CID. 2004;38:1754-60.
26. Rich JD, Holmes L, Salas C, Macalino G, Davis D, Ryczek J, et al. Successful linkage of medical care and community services for HIV-positive offenders being released from prison. J Urban Health. 2001;78(2):279-89.
27. Centers for Disease Control and Prevention. Centers for Disease Control Prevention. Program collaboration and service integration: enhancing the prevention and control of HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis in the United States. US Department of Health and Human Services; 2009.
28. Cheever LW. Engaging HIV-infected patients in care: their lives depend on it. CID. 2007;44:1500-2.
29. Cunningham WE, Anderson RM, Katz MH, Stein MD, Turner BJ, Crystal S, et al. The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Med Care. 1999;37(12):1270-80.
30. Raveis VH, Seigel K, Gorey E. Factors associated with HIV-infected women's delay in seeking medical care. AIDS Care. 1998;10:549-62.
31. Giordano TP, Gifford AL, White CA, Suarez-Almazor ME, Rabeneck L, Hartman C, et al. Retention in care: a challenge to survival with HIV infection. CID. 2007;44:1493-9.
32. Cunningham CO, Sohler NL, Wong MD, Relf M, Cunningham WE, Drainoni ML, et al. Utilization of health care services in hard-to-reach marginalized HIV-infected individuals. AIDS Patient Care STDs. 2007;21(3):177-86.